Lipella Pharmaceuticals Inc. (LIPO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lipella Pharmaceuticals I...

    NASDAQ: LIPO · Real-Time Price · USD
    0.56
    -0.00 (-0.25%)
    At close: Oct 03, 2025, 11:22 AM
    0.56
    0.00%
    Pre-market: Oct 03, 2025, 11:22 AM EDT

    Lipella Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 2.18M 3.29M 5.12M 1.41M
    Short-Term Investments
    		 n/a n/a n/a 300.55K
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a -150.82K -204.8K
    Receivables
    		 84.71K 32.29K 113.66K n/a
    Inventory
    		 n/a n/a -113.66K n/a
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 2.62M 3.43M 5.8M 1.81M
    Property-Plant & Equipment
    		 56.62K 147.89K 150.82K 204.8K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 56.62K 147.89K 150.82K 204.8K
    Total Assets
    		 2.67M 3.58M 5.95M 2.01M
    Account Payables
    		 388.19K 138.02K 384.36K 46.9K
    Deferred Revenue
    		 n/a n/a n/a 178.97K
    Short-Term Debt
    		 n/a n/a 275K 25K
    Other Current Liabilities
    		 n/a n/a n/a -357.93K
    Total Current Liabilities
    		 754.42K 385.36K 1.18M 340.63K
    Long-Term Debt
    		 n/a n/a n/a 50K
    Other Long-Term Liabilities
    		 n/a n/a n/a 30.35K
    Total Long-Term Liabilities
    		 n/a 47.37K 96.26K 248.71K
    Total Liabilities
    		 754.42K 432.73K 1.27M 589.34K
    Total Debt
    		 47.6K 136.59K 429.52K 282.96K
    Book Value
    		 1.92M 3.14M 4.68M 1.42M
    Book Value Per Share
    		 1.83 4.19 9.22 3.05
    Common Stock
    		 121.00 605.00 574.00 967.00
    Retained Earnings
    		 -15.34M -10.32M -5.7M -3.11M
    Comprehensive Income
    		 n/a n/a n/a -3.11M
    Shareholders Equity
    		 1.92M 3.14M 4.68M 1.42M
    Total Investments
    		 n/a n/a n/a 300.55K

    Add to Watchlist